Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Cheng-Lai

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Heart Disease (Hagerstown, Md.)|April 27, 2002
Eprosartan: an angiotensin-II receptor antagonist for the management of hypertensionAngela Cheng-Lai
Heart Disease (Hagerstown, Md.)|January 29, 2003
Rosuvastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemiaAngela Cheng-Lai
Cardiology in Review|April 6, 2017
Inhaled Insulin: A Clinical and Historical ReviewJason Chan, Angela Cheng-Lai
Cardiology in Review|December 7, 2011
Linagliptin: the newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitusRachael Aletti, Angela Cheng-Lai
Cardiology in Review|April 6, 2011
Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarinArlene Tran, Angela Cheng-Lai
Cardiology in Review|August 12, 2010
Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemiaHaniyyah Ahmad, Angela Cheng-Lai
Cardiology in Review|September 29, 2012
The polypill: a potential global solution to cardiovascular diseaseCaroline Nguyen, Angela Cheng-Lai
Cardiology in Review|April 23, 2009
Clevidipine: a novel ultra-short-acting calcium antagonistLendita Prlesi, Angela Cheng-Lai
Cardiology in Review|August 20, 2009
Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillationDanielle Garcia, Angela Cheng-Lai
Cardiology in Review|December 6, 2013
New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia)Grace Shyh, Angela Cheng-Lai
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Heart Disease (Hagerstown, Md.)|April 27, 2002
Eprosartan: an angiotensin-II receptor antagonist for the management of hypertensionAngela Cheng-Lai
Heart Disease (Hagerstown, Md.)|January 29, 2003
Rosuvastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemiaAngela Cheng-Lai
Cardiology in Review|April 6, 2017
Inhaled Insulin: A Clinical and Historical ReviewJason Chan, Angela Cheng-Lai
Cardiology in Review|December 7, 2011
Linagliptin: the newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitusRachael Aletti, Angela Cheng-Lai
Cardiology in Review|April 6, 2011
Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarinArlene Tran, Angela Cheng-Lai
Cardiology in Review|August 12, 2010
Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemiaHaniyyah Ahmad, Angela Cheng-Lai
Cardiology in Review|September 29, 2012
The polypill: a potential global solution to cardiovascular diseaseCaroline Nguyen, Angela Cheng-Lai
Cardiology in Review|April 23, 2009
Clevidipine: a novel ultra-short-acting calcium antagonistLendita Prlesi, Angela Cheng-Lai
Cardiology in Review|August 20, 2009
Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillationDanielle Garcia, Angela Cheng-Lai
Cardiology in Review|December 6, 2013
New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia)Grace Shyh, Angela Cheng-Lai
Pageof 3